Purchases and Sales Made in Q3 2022 in Akero Therapeutics, Inc. (AKRO)
This table provides information about the institutional ownership of Akero Therapeutics, Inc. (AKRO) during Q3 2022. The information is specifically focused on institutions that hold shares of Akero Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 07, 2022
Q3 2022
|
Nisa Investment Advisors, LLC
|
BUY
|
- |
21New |
$213 - $715
|
21
$672
|
|
|
Nov 10, 2022
Q3 2022
|
Pnc Financial Services Group, Inc.
Pittsburgh, PA |
BUY
|
- |
15New |
$152 - $511
|
15
$480
|
|
|
Nov 08, 2022
Q3 2022
|
Ifp Advisors, Inc
|
BUY
|
- |
2New |
$20.3 - $68.1
|
2
$64
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-67- 3.72% |
$680 - $2.28K
|
1.74K
$55.5K
|
|
|
Jun 14, 2023
Q3 2022
|
Metropolitan Life Insurance CO
New York, NY |
SELL
|
- |
-205- 10.35% |
$2.08K - $6.98K
|
1.78K
$56.8K
|
|
|
Nov 14, 2022
Q3 2022
|
Alps Advisors Inc
Denver, CO |
SELL
|
- |
-229- 1.1% |
$2.32K - $7.8K
|
20.5K
$658K
|
|
|
Nov 14, 2022
Q3 2022
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-403- 11.54% |
$4.09K - $13.7K
|
3.09K
$98.9K
|
|
|
Nov 02, 2022
Q3 2022
|
Victory Capital Management Inc
|
SELL
|
- |
-702- 3.52% |
$7.13K - $23.9K
|
19.2K
$615K
|
|
|
Nov 09, 2022
Q3 2022
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-745- 93.13% |
$7.56K - $25.4K
|
55
$1.76K
|
|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
SELL
|
- |
-1.88K- 46.06% |
$19.1K - $63.9K
|
2.2K
$70.4K
|
|
|
Nov 09, 2022
Q3 2022
|
Silvant Capital Management LLC
|
SELL
|
- |
-1.91K- 45.28% |
$19.4K - $64.9K
|
2.31K
$73.8K
|
|
|
Nov 14, 2022
Q3 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-2.04K- 13.8% |
$20.7K - $69.4K
|
12.7K
$407K
|
|
|
Nov 08, 2022
Q3 2022
|
Woodmont Investment Counsel LLC
Nashville, TN |
SELL
|
- |
-2.5K- 20.63% |
$25.4K - $85.1K
|
9.62K
$308K
|
|
|
Jun 14, 2023
Q3 2022
|
Met Life Investment Management, LLC
Whippany, NJ |
SELL
|
- |
-2.7K- 14.77% |
$27.4K - $91.9K
|
15.6K
$499K
|
|
|
Nov 14, 2022
Q3 2022
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-2.93K- 27.02% |
$29.7K - $99.6K
|
7.9K
$253K
|
|
|
Nov 14, 2022
Q3 2022
|
Ergoteles LLC
New York, NY |
SELL
|
- |
-3K- 15.54% |
$30.5K - $102K
|
16.3K
$522K
|
|
|
Oct 31, 2022
Q3 2022
|
Sg Americas Securities, LLC
|
SELL
|
- |
-5.31K- 24.81% |
$53.9K - $181K
|
16.1K
$515K
|
|
|
Nov 08, 2022
Q3 2022
|
State Board Of Administration Of Florida Retirement System
|
SELL
|
- |
-7.14K- 41.64% |
$72.4K - $243K
|
10K
$320K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-7.14K- 87.38% |
$72.4K - $243K
|
1.03K
$33K
|
|
|
Nov 14, 2022
Q3 2022
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-9.26K- 27.35% |
$94K - $315K
|
24.6K
$788K
|
|
|
Nov 03, 2022
Q3 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-10.9K- 90.16% |
$111K - $371K
|
1.19K
$38K
|
|
|
Nov 14, 2022
Q3 2022
|
Pdt Partners, LLC
New York, NY |
SELL
|
- |
-14.3K- 36.73% |
$145K - $486K
|
24.6K
$787K
|
|
|
Nov 14, 2022
Q3 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-15K- 62.76% |
$152K - $511K
|
8.9K
$285K
|
|
|
Nov 14, 2022
Q3 2022
|
Occudo Quantitative Strategies LP
Fort Lauderdale, FL |
SELL
|
- |
-20.5K- 64.08% |
$208K - $696K
|
11.5K
$367K
|
|
|
Mar 03, 2023
Q3 2022
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-25.8K- 70.22% |
$262K - $879K
|
10.9K
$350K
|
|
|
Nov 22, 2022
Q3 2022
|
Teachers Retirement System Of The State Of Kentucky
Frankfort, KY |
SELL
|
- |
-35.4KClosed |
$359K - $1.2M
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-57.7K- 47.37% |
$586K - $1.96M
|
64.1K
$2.05M
|
|
|
Nov 14, 2022
Q3 2022
|
Integral Health Asset Management, LLC
|
SELL
|
- |
-58.1K- 20.15% |
$589K - $1.98M
|
230K
$7.36M
|
|
|
Nov 10, 2022
Q3 2022
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-70.6K- 19.5% |
$717K - $2.4M
|
291K
$9.33M
|
|
|
Nov 14, 2022
Q3 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-255K- 25.34% |
$2.59M - $8.68M
|
751K
$24M
|
|
|
Nov 14, 2022
Q3 2022
|
Hhlr Advisors, Ltd.
Grand Cayman, E9 |
SELL
|
- |
-679K- 49.97% |
$6.89M - $23.1M
|
680K
$21.8M
|
|
|
Nov 09, 2022
Q3 2022
|
Atlas Venture Life Science Advisors, LLC
|
SELL
|
- |
-1.24M- 55.46% |
$12.6M - $42.2M
|
994K
$31.8M
|
|
|
Nov 14, 2022
Q3 2022
|
Ven Bio Partners LLC
San Francisco, CA |
SELL
|
- |
-1.58M- 72.53% |
$16M - $53.6M
|
596K
$19.1M
|